Evidence map›Paper›PMID 20735141›Full record

ArticleMolecular pharmaceutics2010

Evolutionary selection of new breast cancer cell-targeting peptides and phages with the cell-targeting peptides fully displayed on the major coat and their effects on actin dynamics during cell internalization.

Gopal Abbineni, Sita Modali, Barbara Safiejko-Mroczka, Valery A Petrenko, Chuanbin Mao

Abstract read
In one paragraph

Article in Molecular pharmaceutics, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
3.0field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 71 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Article
  6. Review
  7. [Bacteriophage Therapy: Retrospective Review and Future Prospects].Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition · 2021
    Review
  8. A binuclear iron(III) complex of 5,5'-dimethyl-2,2'-bipyridine as cytotoxic agent.Biometals : an international journal on the role of metal ions in biology, biochemistry, and medicine · 2020
    Article
  9. Article
  10. Enhancement of Photodynamic Cancer Therapy by Physical and Chemical Factors.Angewandte Chemie (International ed. in English) · 2019
    Review
  11. Article
  12. Nanomaterials as photothermal therapeutic agents.Progress in materials science · 2019
    Article
  13. Article
  14. Review
  15. Phage-Enabled Nanomedicine: From Probes to Therapeutics in Precision Medicine.Angewandte Chemie (International ed. in English) · 2017
    Review
  16. Article
  17. Article
  18. Biomimetic Crystallization of MnFeChemNanoMat : chemistry of nanomaterials for energy, biology and more · 2016
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Gopal AbbineniDepartment of Chemistry and Biochemistry and Department of Zoology, The University of Oklahoma, Norman, OK 73019, USA.
Sita Modali
Barbara Safiejko-Mroczka
Valery A Petrenko
Chuanbin Mao
University of Oklahoma · USAuburn University · US

Funding

Drug Delivery Carriers Targeted to Breast Tumor by Fusion Phage ProteinsR01CA125063 · NCI · AUBURN UNIVERSITY AT AUBURN · PI PETRENKO, VALERY A. · 2007 to 2011
$1.9M
Phage-inspired nanoparticles with genetically tunable target-specificityR01HL092526 · NHLBI · UNIVERSITY OF OKLAHOMA · PI MAO, CHUANBIN · 2009 to 2010
$806k
Phage-Mimetic Nanorods for Targeted Breast Cancer TreatmentR21EB009909 · NIBIB · UNIVERSITY OF OKLAHOMA · PI MAO, CHUANBIN · 2009 to 2010
$399k
Bone-seeking and cell-targeting non-viral vectors for BMP-2 gene deliveryR03AR056848 · NIAMS · UNIVERSITY OF OKLAHOMA · PI MAO, CHUANBIN · 2009 to 2011
$222k
NCI NIH HHS 5R01CA125063-03NCI NIH HHS R01 CA125063NHLBI NIH HHS R01 HL092526NIAMS NIH HHS R03 AR056848NIBIB NIH HHS R21 EB009909NIBIB NIH HHS R21EB009909-01A1
6 · The paper itself

Abstract

Filamentous phage as a bacteria-specific virus can be conjugated with an anticancer drug and has been proposed to serve as a carrier to deliver drugs to cancer cells for targeted therapy. However, how cell-targeting filamentous phage alone affects cancer cell biology is unclear. Phage libraries provide an inexhaustible reservoir of new ligands against tumor cells and tissues that have potential therapeutic and diagnostic applications in cancer treatment. Some of these identified ligands might stimulate various cell responses. Here we identified new cell internalizing peptides (and the phages with such peptides fused to each of ~3900 copies of their major coat protein) using landscape phage libraries and for the first time investigated the actin dynamics when selected phages are internalized into the SKBR-3 breast cancer cells. Our results show that phages harboring VSSTQDFP and DGSIPWST peptides could selectively internalize into the SKBR-3 breast cancer cells with high affinity, and also show rapid involvement of membrane ruffling and rearrangements of actin cytoskeleton during the phage entry. The actin dynamics was studied by using live cell and fluorescence imaging. The cell-targeting phages were found to enter breast cancer cells through energy dependent mechanism and phage entry interferes with actin dynamics, resulting in reorganization of actin filaments and increased membrane rufflings in SKBR-3 cells. These results suggest that, when phage enters epithelial cells, it triggers transient changes in the host cell actin cytoskeleton. This study also shows that using multivalent phage libraries considerably increases the repertoire of available cell-internalizing ligands with potential applications in targeted drug delivery, imaging, molecular monitoring and profiling of breast cancer cells.

Indexed as

ActinsAmino Acid SequenceAntineoplastic AgentsBreast NeoplasmsCell Line, TumorDirected Molecular EvolutionDrug CarriersDrug Delivery SystemsFemaleHumansInovirusLigandsMicroscopy, VideoOligopeptidesOncolytic VirotherapyPeptide LibraryActinsAntineoplastic AgentsDrug CarriersLigandsOligopeptidesPeptide Library

Identifiers

PMID20735141
PMCPMC3021627
OpenAlexW1998122156

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.